Dev Labtech Venture board to meet Oct 7 for capital raise and preferential allotment
- Board meeting scheduled for October 7, 2026, in Surat
- Agenda includes increasing authorized share capital
- Proposal to raise funds via preferential allotment of equity or convertible securities
- Trading window closed from October 2, 2026, until 48 hours post-disclosure

*this image is generated using AI for illustrative purposes only.
Dev Labtech Venture Limited scheduled a Board of Directors meeting for October 7, 2026, to consider raising funds through preferential allotment. The agenda includes increasing the company's authorized share capital.
The meeting is set for 3:00 pm at the company's office in Surat, Gujarat. The primary business to be transacted involves evaluating proposals for issuing equity shares or other eligible convertible securities. This capital raise is subject to regulatory and statutory approvals, including shareholder consent.
Regulatory Compliance and Trading Window
In line with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company informed BSE Limited of the board meeting. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, a trading window closure has been implemented.
The trading window for dealing in securities by insiders and designated persons remains closed from October 2, 2026, until 48 hours after the declaration of undisclosed price-sensitive information becomes generally available.
Agenda Details
| Item | Description |
|---|---|
| Capital Structure | Increase in authorized share capital |
| Fund Raising | Preferential allotment of equity or convertible securities |
| Approvals | Subject to regulatory and shareholder approval |
The company stated that the fund-raising exercise will proceed only after obtaining all necessary regulatory and statutory clearances. The specific amount or valuation details were not disclosed in the intimation notice.
Historical Stock Returns for Dev Labtech Venture
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -10.24% | -4.82% | 0.0% | -19.83% | 0.0% | +49.48% |
Which specific institutional or strategic investors are expected to participate in the preferential allotment, and what valuation premium might they demand?
How will the planned increase in authorized share capital impact the company's future dilution profile for existing retail shareholders?
What specific growth initiatives or operational expansions is Dev Labtech Venture Limited aiming to fund with the proceeds from this capital raise?






























